| Literature DB >> 27439526 |
Peter J Collignon1,2, John M Conly3, Antoine Andremont4, Scott A McEwen5, Awa Aidara-Kane6, Yvonne Agerso, Antoine Andremont4, Peter Collignon, John Conly, Tran Dang Ninh, Pilar Donado-Godoy, Paula Fedorka-Cray, Heriberto Fernandez, Marcelo Galas, Rebecca Irwin, Beth Karp, Gassan Matar, Patrick McDermott, Scott McEwen, Eric Mitema, Richard Reid-Smith, H Morgan Scott, Ruby Singh, Caroline Smith DeWaal, John Stelling, Mark Toleman, Haruo Watanabe, Gun-Jo Woo.
Abstract
Antimicrobial use in food animals selects for antimicrobial resistance in bacteria, which can spread to people. Reducing use of antimicrobials-particularly those deemed to be critically important for human medicine-in food production animals continues to be an important step for preserving the benefits of these antimicrobials for people. The World Health Organization ranking of antimicrobials according to their relative importance in human medicine was recently updated. Antimicrobials considered the highest priority among the critically important antimicrobials were quinolones, third- and fourth-generation cephalosporins, macrolides and ketolides, and glycopeptides. The updated ranking allows stakeholders in the agriculture sector and regulatory agencies to focus risk management efforts on drugs used in food animals that are the most important to human medicine. In particular, the current large-scale use of fluoroquinolones, macrolides, and third-generation cephalosporins and any potential use of glycopeptides and carbapenems need to be addressed urgently.Entities:
Keywords: animals; antimicrobial resistance; antimicrobials; food production; risk management
Mesh:
Substances:
Year: 2016 PMID: 27439526 DOI: 10.1093/cid/ciw475
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079